Produced in collaboration with The Leukemia & Lymphoma Foundation
Support for this patient education program was provided by Seattle Genetics, Inc.
Peripheral T-cell lymphomas (PTCLs) are uncommon and aggressive types of non-Hodgkin lymphoma (NHL) that develop in mature white blood cells called “T cells” and “natural killer,” or NK, cells. Join this special educational program to hear from clinical specialists, advocates, and families facing PTCLs as they review:
- What information is included in a pathology report, and how it is used to select therapy
- Why a treatment may be switched if there is a relapse
- Effective communication with physicians, including tips for asking questions and seeking a second opinion
Steven Horwitz, MD
Memorial Sloan Kettering Cancer Center
The Leukemia & Lymphoma Society
Meredith Barnhart is the director of the Information Resource Center at The Leukemia & Lymphoma Society in Rye Brook, New York. She oversees a team of information specialists, who field inquiries from blood cancer patients and their loved ones. Meredith and her team provide comprehensive, personalized, and up-to-date information on the blood cancers, treatment options including clinical trials, and support and financial resources. Her research focuses on the experiences and needs of families with multiple incidences of cancers. She received her master’s degree from Columbia University and is currently pursuing a PhD in social work from the Graduate School of Social Service at Fordham University in New York, New York.